Structural Formula (Image 01)
Yutrepia Capsule
Product Images NDC 72964-014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Yutrepia (NDC 72964-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Liquidia Technologies, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Image 02)
Figure 2 (Image 03)
Figure 3 (Image 04)
Figure 4 (Image 05)
Figure 5 (Image 06)
Figure A (IFU)
Figure B (IFU)
Figure C (IFU)
Figure D (IFU)
Figure E (IFU)
Figure F (IFU)
Figure G (IFU)
Figure H (IFU)
Figure I (IFU)
Figure J (IFU)
Figure K (IFU)
Figure L (IFU)
Figure M (IFU)
Figure N (IFU)
Figure O (IFU)
Figure P (IFU)
Figure Q (IFU)
Figure R (IFU)
Figure S (IFU)
When Dosing With More Than One Capsule... (Image 26)
This text provides instructions on dosing with more than one capsule when the prescribed dose is 132.5 mcg or larger. It explains that if multiple capsules are needed to complete the dose, the steps from 4 to 13 should be repeated for each additional capsule. Additionally, it mentions that the order in which the capsules are dosed does not matter regardless of their strength.*
Figure T (IFU)
Figure U (IFU)
Figure V (IFU)
Figure W (IFU)
Figure X (IFU)
Principal Display Panel (26.5 mcg Carton)
Principal Display Panel (53 mcg Carton)
Not available.*
Principal Display Panel (79.5 mcg Carton)
This document appears to be a pharmaceutical label for an inhalation powder medication called Yutreplo. It provides instructions for use, dosage information, storage guidelines, and warnings to keep the medication out of reach of children. The label also includes lot number and copyright information for Liquidia, the company that manufactures the product.*
Principal Display Panel (106 mcg Carton)
This is a prescription label for Yutrepro inhalation powder containing treprostinil. The recommended dosage instructions and storage conditions are provided on the label. It is important to keep the medication out of reach of children and not remove the capsules from the blister pack until ready to use. Be sure to follow the prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
